Free Newsletter
Researchers identify Tysabri-PML link
The multiple sclerosis drug Tysabri awakens a virus that causes a rare brain disease, not only suppressing the body's ability to fight it but making the virus stronger, U.S. researchers found. Report
Comments
By TRH_Orlando | Posted 5:01pm | September 17, 2009
Your comments to previous post are most welcome!
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: